Scalable GMP Manufacturing for Live Biotherapeutics

State-of-the-art multi-product live biotherapeutics facility online in Fishers, IN in Q4 2024.

Scalable GMP Manufacturing for Live Biotherapeutics

State-of-the-art multi-product live biotherapeutics facility online in Fishers, IN in Q4 2024.

Scalable GMP Live Biotherapeutic Manufacturing

List Labs is proud to announce the upcoming launch of our facility in Fishers, Indiana. Spanning over 120,000 square feet, this state-of-the-art cGMP compliant manufacturing facility designed to meet global standards is slated to go online in Q4 2024.

The multi-product facility represents a major step forward in our commitment to delivering a comprehensive end-to-end solution, including scalable capabilities for:

Aerobic Organisms
Obligate and Facultative Anaerobes

With a focus on supporting microbiome-based therapeutics for both spore-forming and non-spore forming microorganism production, this facility offers a broad range of processing capabilities that support Phase III through commercial manufacturing demand.
Our Fishers, IN facility is set to be a game-changer in the industry, propelling List Labs to the forefront of innovation in delivering best-in-class CDMO solutions.

Non-Spore Forming & Spore-
Forming Microorganisms
BSL1, BSL2, and GMO

LBP At Your Fingertips, Worldwide

The Fishers, IN facility represents another step toward List Labs’ goal of delivering innovative, end-to-end LBP manufacturing solutions for a healthier world. With 17.5 acres we are excited to continue our expansion efforts with advanced technology and look forward to being able to better serve a broad range of clients in markets around the world

List Labs’ Commercial Facility

List Labs’ multi-product facility sets the standard for excellence in bacterial therapeutics, offering state-of-the-art technology and a commitment to quality. With strict anaerobic microorganism handling processes and optimal control for process conditions, we ensure the highest levels of purity and efficacy for all our clients’ products. Additionally, we have broad strain experience, having worked with over 100 strains, making us a trusted partner for microbiome-based therapeutics. The Fisher, IN facility will host:

Anaerobic Microbial Controls
Single Use Technology
Advanced Drying Technology
Analytical Method Development
Regulatory CMC Services

Our unique facility for spore-forming bacteria production in the US is a testament to our commitment to innovation and customer service. Our team takes pride in providing tailored process development and production for LBP, ensuring that each customer receives the exact solution required to meet their unique needs, and securing List Labs as the ideal LBP CDMO partner.

A Commitment to Excellence in LBP Manufacturing

List Labs is a trusted CDMO, offering end-to-end solutions, technical expertise, and global capabilities for the production of live biotherapeutics. Our commitment to scientific and operational excellence affirms List Labs as the ideal partner for customers in emerging markets around the world.

As a global leader in LBP manufacturing, List Labs delivers innovative, high-quality solutions for microbiome-based therapeutics. With our strategic CDMO partnership and commitment to excellence, we can provide unparalleled service and value to your LBP project.